Intercure Ltd.

The momentum for this stock is not very good. Intercure Ltd. is not very popular among insiders. Tradey thinks it is not wise to invest in Intercure Ltd..
Log in to see more information.

News

InterCure reports 1H results
InterCure reports 1H results

Seeking Alpha - Israel Stocks InterCure reports 1H results...\n more…

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

Globe Newswire Revenues during the first half of 2024 reached NIS 126 million, alongside an Adjusted EBITDA1of NIS 21 million (Approximately 17% of revenues).Both quarters (Q1 and Q2 of 2024) ended with positive...\n more…

InterCure announces expansion of partnership with Cookies to Germany
InterCure announces expansion of partnership with Cookies to Germany

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

InterCure expands strategic partnership with Cookies to Germany
InterCure expands strategic partnership with Cookies to Germany

Seeking Alpha - Israel Stocks InterCure expands strategic partnership with Cookies to Germany...\n more…

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

Business Wire InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ('InterCure' or the 'Company'), the leading vertically integrated medical cannabis company outside of North America, is announcing a new...\n more…

InterCure: A Cannabis Industry Leader Still Flying Under The Radar
InterCure: A Cannabis Industry Leader Still Flying Under The Radar

Seeking Alpha - Long Ideas InterCure: A Cannabis Industry Leader Still Flying Under The Radar...\n more…